Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

View:
Post by polygraph46 on Apr 05, 2021 7:47pm

Re: News

Oh my!!
Just reading the news of the day.  As a holder, I'm pissed.  Kaly presenting with a new name and potential roll back. This is far from stellar news.  Management's tactic in changing name and taking Kaly madly off in a quacky direction, does not come close to passing the smell test. And forget about the Company's absolutely abysmal performance over the past years? Yet, the evisceration continues.  Read on.
Potential rollback( 20 for 1) aka "kiss of death".  Why is the Kaly braintrust using the term potential re: the rollback when it's inevitable?  Remember, the Company has no sinking fund to fall back on.
Remember also, we just came off that unprecedented six month halt. Obviously, the Venture Exchange took an exceedingly hard look before finally lifting. Well, once again, given Kaly's checkered past, like it or not, there will be serious challenges for this proposal to pass muster with the exchange.  
Reality is that Kaly needs much cashola as it has little, and thus, the rollback will happen on our backs. Our hard earned cash getting diced up with the big twenty to one shrink. Lovely, just freaking lovely.  I only have a paltry 70,000 shares left.  Please, all you pump-a-doodles, get this to 0.06 and I'll bite.....pg46
Comment by Scotty on Apr 05, 2021 8:17pm
Oof, 20:1? Pg46 you might have to cut your losses when this gets passed unfortunately. KLY/CLAS will be shorted into the ground, it's guarenteed free money, Sorry :(.